We and others have shown that genes involved in homologous recombination repair are important in both gastric cancer risk and tumorigenesis (73–75), which is consistent with our observation of multiple patients with clonal nonsilent mutations in ATR, ATM, and BRCA2 and with the mostly clonal nature of the HRd-associated mutation. This evidence concerns the gene BRCA2 and gastric cancer.